verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: somerset therapeutics, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler somerset therapeutics, llc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Somerset Therapeutics, LLC

Identifiers & Regulatory

Product NDC 70069-273
Product ID 70069-273_6d4f205d-626c-4285-ba7b-c0ca536c7875
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211035
Listing Expiration 2026-12-31
Marketing Start 2018-06-18

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70069273
Hyphenated Format 70069-273

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0370069272015 0370069273012 0370069271018
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA211035 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 5 AMPULE in 1 TRAY (70069-273-05) / 2 mL in 1 AMPULE (70069-273-01)
source: ndc

Packages (1)

70069-273-05 5 AMPULE in 1 TRAY (70069-273-05) / 2 mL in 1 AMPULE (70069-273-01)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "6d4f205d-626c-4285-ba7b-c0ca536c7875", "openfda": {"upc": ["0370069272015", "0370069273012", "0370069271018"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["50131bbc-ad43-4708-946f-e4000828137c"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 AMPULE in 1 TRAY (70069-273-05)  / 2 mL in 1 AMPULE (70069-273-01)", "package_ndc": "70069-273-05", "marketing_start_date": "20180618"}], "brand_name": "Verapamil Hydrochloride", "product_id": "70069-273_6d4f205d-626c-4285-ba7b-c0ca536c7875", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "70069-273", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA211035", "marketing_category": "ANDA", "marketing_start_date": "20180618", "listing_expiration_date": "20261231"}